(R)-Preclamol(Cat No.:I045128)is the R-enantiomer of preclamol, a dopamine receptor modulator with partial agonist activity at D<sub>2</sub> and D<sub>3</sub> receptors and antagonist activity at D<sub>1</sub> receptors. It has been investigated for its antipsychotic and antiparkinsonian potential due to its ability to stabilize dopaminergic signaling. Unlike full antagonists, (R)-Preclamol’s partial agonism may reduce side effects like motor disturbances and hyperprolactinemia. It is used in preclinical research to study dopamine-related neuropsychiatric disorders, including schizophrenia and Parkinson’s disease. Supplied for research in dopaminergic modulation and central nervous system pharmacology.